Abstract:We present clinical outcome, through several years of follow-up, of 4 mentally retarded patients, each with a small interstitial deletion in the long arm of chromosome 2, within a region on which clinical reports are infrequent. Our patient 1 was found to have del(2)(q22.3q23.3); patients 2 and 3, del(2)(q23.3q24.2); and patient 4, del(2) (q24.2q31). By comparison of our cases with each other and with those previously published with comparable interstitial deletion, we attempted to identify characteristic clin… Show more
“…Seizures are frequent but inconsistent in those circumstances, as opposed to seizures which are a characteristic finding in the submicroscopic cases. The pattern of clinical features has sometimes been described quite close to our “pseudo-Angelman” patients19 but a more malformative VATER-like phenotype has also been reported in a girl with a 2q22q24.2 deletion 20. However, the boundaries of the previously described 2q22q24 deletions were determined only by banding techniques and it is difficult to conclude if these deletions correspond to the highly resolved boundaries determined by array CGH.…”
Haploinsufficiency of one of the deleted genes (MBD5 or EPC2) could be responsible for the common clinical features observed in the 2q23.1 microdeletion syndrome, and this hypothesis needs further investigation.
“…Seizures are frequent but inconsistent in those circumstances, as opposed to seizures which are a characteristic finding in the submicroscopic cases. The pattern of clinical features has sometimes been described quite close to our “pseudo-Angelman” patients19 but a more malformative VATER-like phenotype has also been reported in a girl with a 2q22q24.2 deletion 20. However, the boundaries of the previously described 2q22q24 deletions were determined only by banding techniques and it is difficult to conclude if these deletions correspond to the highly resolved boundaries determined by array CGH.…”
Haploinsufficiency of one of the deleted genes (MBD5 or EPC2) could be responsible for the common clinical features observed in the 2q23.1 microdeletion syndrome, and this hypothesis needs further investigation.
“…These findings further support the contention that one or more genes involved in craniofacial development are harboured at these loci, although micrognathia may also be viewed as a common, non-specific feature of such deletions. 43 There is only a single reported case of non-syndromic RS implicating 2q32 35 but no evidence of a locus at 2q23-24. In contrast, four examples of RS including the current study have been described with translocations involving the 17q23.3-17q25 region 33 34 36 (table 1).…”
“…Some chromosomal interstitial deletions reported in combination with HSCR, have been important for the identification of HSCR predisposing genes, namely: (1) 10q11.2 interstitial deletion observed in a few patients with L-HSCR or TCA38 146 leading to the mapping and identification of the first HSCR predisposing gene ( RET ); (2) 13q22.1-32.1 interstitial deletion in patients with S-HSCR leading to the mapping of the second gene ( EDNRB )164 – 166; (3) 2q22-23 interstitial deletion syndrome in patients with a multiple congenital anomaly–mental retardation (MCA-MR) syndrome with HSCR or severe chronic constipation further delineated as Mowat-Wilson syndrome (table 3),133 134 147 leading to the identification of the ZFHX1B gene (previously named SIP1 gene) 135…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.